Semaglutide → Vomiting — Audit-grade candidate (scan)

← All findings ⬇ Download signed audit packet

Ledger entry · candidate

Semaglutide → Vomiting — Audit-grade candidate (scan)

Drug: semaglutide · AE: Vomiting

Discovered via single-drug scan of semaglutide. PRR = 4.23 (95% CI 4.08–4.40), n = 2516 cases. Pre-reg locked at submission time.

Disproportionality

PRR: 4.234364025361064 (95% CI 4.08–4.40)
Yates χ²: 6323.677189815963
Cases (case-drug + AE): n = 2516
Verdict: PASSES_ALL_GATES — PRR=4.23 (95% CI 4.08–4.40), n=2516 cases; flagged for clinical expert review, NOT for external escalation without manual verification

Top reactions in cohort

MedDRA PT	n
No reactions surfaced in cohort.

Source: openFDA FAERS, Caliper Engine v0. Pre-registration sha1 locked at submission time; ledger entry signed with platform Ed25519 key.

Independent Verification & Validation

Every finding includes an in-engine adversary review at no cost. For findings you plan to cite in a regulatory submission, scientific publication, or board-grade decision, we offer an additional layer of independent, audit-grade verification — reviewed by an externally-trained system that has never seen your data, your training corpus, or our hardware, and cryptographically signed.

Reference: ff1b0925e594a184ab73d46175b0939e7315c52f